NO20062100L - Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents
Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende demInfo
- Publication number
- NO20062100L NO20062100L NO20062100A NO20062100A NO20062100L NO 20062100 L NO20062100 L NO 20062100L NO 20062100 A NO20062100 A NO 20062100A NO 20062100 A NO20062100 A NO 20062100A NO 20062100 L NO20062100 L NO 20062100L
- Authority
- NO
- Norway
- Prior art keywords
- processes
- preparation
- new
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- JLECMXGHGHVRFB-UHFFFAOYSA-N 2-phenyl-1-pyridin-2-ylpiperazine Chemical class C1NCCN(C=2N=CC=CC=2)C1C1=CC=CC=C1 JLECMXGHGHVRFB-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Forbindelser med formel (I): hvori: R1 representerer en NR.3SO2R4-gruppe hvori: R3 representerer et hydrogenatom eller en alkylgruppe, R4 representerer en alkylgruppe, arylgruppe eller NR5R6-gruppe, R2 representerer en alkyl-, cykloalkyl- eller cykloalkylalkylgruppe. Medikamenter.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0504757A FR2885615B1 (fr) | 2005-05-12 | 2005-05-12 | Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062100L true NO20062100L (no) | 2006-11-13 |
Family
ID=35677562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062100A NO20062100L (no) | 2005-05-12 | 2006-05-10 | Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (21)
Country | Link |
---|---|
US (1) | US7494995B2 (no) |
EP (1) | EP1721896A1 (no) |
JP (1) | JP2006342158A (no) |
KR (1) | KR100807482B1 (no) |
CN (1) | CN100540536C (no) |
AR (1) | AR054120A1 (no) |
AU (1) | AU2006201993A1 (no) |
BR (1) | BRPI0601725A (no) |
CA (1) | CA2546387A1 (no) |
EA (1) | EA011165B1 (no) |
FR (1) | FR2885615B1 (no) |
GE (1) | GEP20084503B (no) |
HK (1) | HK1096097A1 (no) |
MA (1) | MA28325A1 (no) |
MY (1) | MY140963A (no) |
NO (1) | NO20062100L (no) |
NZ (1) | NZ547121A (no) |
SG (1) | SG127800A1 (no) |
UA (1) | UA87283C2 (no) |
WO (1) | WO2006120348A1 (no) |
ZA (1) | ZA200603809B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
RU2499795C2 (ru) | 2005-07-04 | 2013-11-27 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
EP2079732B9 (en) * | 2006-05-29 | 2012-03-21 | High Point Pharmaceuticals, LLC | 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
EP2014656A3 (en) * | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
JP2013532688A (ja) | 2010-07-26 | 2013-08-19 | ブリストル−マイヤーズ スクイブ カンパニー | Cyp17阻害剤として有用なスルホンアミド化合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019574A (en) * | 1988-09-30 | 1991-05-28 | Chugai Seiyaku Kabushiki Kaisha | 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function |
JP2563402Y2 (ja) * | 1989-09-28 | 1998-02-25 | 株式会社小松製作所 | ディーゼルエンジンのピストン |
CA2089728A1 (en) * | 1990-09-13 | 1992-03-14 | James S. Frazee | Pyridylthio or pyridyloxy alkanoic acids |
WO1998015548A1 (en) * | 1996-10-04 | 1998-04-16 | Novo Nordisk A/S | 1,4-disubstituted piperazines |
DE69839887D1 (de) * | 1997-10-02 | 2008-09-25 | Eisai R&D Man Co Ltd | Kondensierte pyridinderivate |
SK285198B6 (sk) * | 1997-10-27 | 2006-08-03 | Neurosearch A/S | Homopiperazínový derivát, farmaceutická kompozícia obsahujúca tento derivát a jeho použitie |
GB9919776D0 (en) * | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
-
2005
- 2005-05-12 FR FR0504757A patent/FR2885615B1/fr not_active Expired - Fee Related
-
2006
- 2006-05-02 MA MA28996A patent/MA28325A1/fr unknown
- 2006-05-05 SG SG200603043A patent/SG127800A1/en unknown
- 2006-05-10 NO NO20062100A patent/NO20062100L/no not_active Application Discontinuation
- 2006-05-10 MY MYPI20062153A patent/MY140963A/en unknown
- 2006-05-11 US US11/432,787 patent/US7494995B2/en not_active Expired - Fee Related
- 2006-05-11 NZ NZ547121A patent/NZ547121A/en unknown
- 2006-05-11 GE GEAP20069392A patent/GEP20084503B/en unknown
- 2006-05-11 WO PCT/FR2006/001049 patent/WO2006120348A1/fr active Application Filing
- 2006-05-11 UA UAA200605181A patent/UA87283C2/ru unknown
- 2006-05-11 EP EP06290757A patent/EP1721896A1/fr not_active Withdrawn
- 2006-05-11 AR ARP060101888A patent/AR054120A1/es unknown
- 2006-05-12 JP JP2006133321A patent/JP2006342158A/ja active Pending
- 2006-05-12 AU AU2006201993A patent/AU2006201993A1/en not_active Abandoned
- 2006-05-12 BR BRPI0601725-8A patent/BRPI0601725A/pt not_active IP Right Cessation
- 2006-05-12 ZA ZA200603809A patent/ZA200603809B/xx unknown
- 2006-05-12 CA CA002546387A patent/CA2546387A1/fr not_active Abandoned
- 2006-05-12 KR KR1020060042827A patent/KR100807482B1/ko not_active IP Right Cessation
- 2006-05-12 EA EA200600761A patent/EA011165B1/ru not_active IP Right Cessation
- 2006-05-12 CN CNB2006101263974A patent/CN100540536C/zh not_active Expired - Fee Related
-
2007
- 2007-03-30 HK HK07103457.3A patent/HK1096097A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MY140963A (en) | 2010-02-12 |
BRPI0601725A (pt) | 2007-05-08 |
WO2006120348A1 (fr) | 2006-11-16 |
KR20060117262A (ko) | 2006-11-16 |
EA011165B1 (ru) | 2009-02-27 |
SG127800A1 (en) | 2006-12-29 |
US20060258671A1 (en) | 2006-11-16 |
FR2885615B1 (fr) | 2007-06-22 |
AU2006201993A1 (en) | 2006-11-30 |
FR2885615A1 (fr) | 2006-11-17 |
ZA200603809B (en) | 2007-08-29 |
US7494995B2 (en) | 2009-02-24 |
UA87283C2 (ru) | 2009-07-10 |
EP1721896A1 (fr) | 2006-11-15 |
HK1096097A1 (en) | 2007-05-25 |
EA200600761A1 (ru) | 2006-12-29 |
JP2006342158A (ja) | 2006-12-21 |
KR100807482B1 (ko) | 2008-02-25 |
AR054120A1 (es) | 2007-06-06 |
MA28325A1 (fr) | 2006-12-01 |
NZ547121A (en) | 2007-05-31 |
CN100540536C (zh) | 2009-09-16 |
CA2546387A1 (fr) | 2006-11-12 |
CN1896062A (zh) | 2007-01-17 |
GEP20084503B (en) | 2008-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062083L (no) | Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20076006L (no) | Acetylenderivater | |
NO20073325L (no) | Nye naftalenforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20083542L (no) | Nye kumarinderivater med antitumoraktivitet | |
NO20055688L (no) | Organiske forbindelser | |
NO20081217L (no) | Nye benzotiazolonderivater | |
NO20050635L (no) | Nye tricykliske spiropiperidiner eller spiropyrrolidiner | |
NO20071504L (no) | Pyrimidinderivanter. | |
NO20054329L (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
NO20083434L (no) | Benzamid- og heteroarenderivater | |
NO20081169L (no) | Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20062900L (no) | Nye forbindelser | |
NO20082975L (no) | Nye cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer | |
HUP0402019A2 (hu) | CCR5 antagonistaként alkalmazható piperidinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
NO20076145L (no) | Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav | |
ME00680B (me) | Nova jedinjenja diozmetina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže | |
NO20055167L (no) | Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20062100L (no) | Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20061045L (no) | Imidazolderivater | |
NO20054092L (no) | Nye tricykliske azepinforbindelser, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20091779L (no) | Nye indolforbindelser en prosess for deres fremstilling og farmasoytiske sammensetninger som inneholder dem | |
NO20074346L (no) | Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20052598L (no) | Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem. | |
NO20055844D0 (no) | Nye benzotiazin og benzotiadiazinforbindelsep fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |